ANTI–IL-13 (CENDAKIMAB) ADMINISTRATION IMPROVES OESOPHAGEAL GENE EXPRESSION IN EOSINOPHILIC OESOPHAGITIS

Julie M. Caldwell  1     Adina Y. Ballaban  1     Jie Li  2     Rachel Maddux  2     Sarah Harris  2     Marc E. Rothenberg  2    
1 Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, United States
2 Bristol Myers Squibb, Princeton, United States

Topic
Oesophagus

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing